A Pilot Study of Genetically Engineered NY-ESO-1 Specific NY-ESO-1ᶜ²⁵⁹T in HLA-A2+ Patients With Synovial Sarcoma
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to GlaxoSmithKline
Related studies linked through entity extraction aliases.
Long-term Ambrisentan Extension Study for Pediatric Patients Who Participated in AMB112529
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Study to Investigate Safety and Efficacy of GSK933776 in Adult Patients With Geographic Atrophy Secondary to Age-related Macular Degeneration
- Status
- COMPLETED
- Phase
- PHASE2
A Study to Evaluate the 24 Hour Spirometric Effect (FEV1) of Fluticasone Furoate/Vilanterol Inhalation Powder (100mcg Fluticasone Furoate (FF)/25mcg Vilanterol (VI)) Compared With Salmeterol/Fluticasone Propionate Inhalation Powder (50mcg Salmeterol/500mcg Fluticasone Propionate (FP))
- Status
- COMPLETED
- Phase
- PHASE3
Immunogenicity and Safety Study of GSK Biologicals' Meningococcal Conjugate Vaccine When Co-administered With Routine Vaccines in Healthy Infants and Toddlers
- Status
- COMPLETED
- Phase
- PHASE3
A Pharmacokinetics Study of the Effects of GSK2118436 on Warfarin, the Effects of Ketoconazole and Gemfibrozil on GSK2118436, and the Effects of Repeat Doses of GSK2118436 in Subjects With BRAF Mutant Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Determination of the Absolute Bioavailability of GSK2118436 Following a Single Oral Dose Co-Administered With an Intravenous Radiolabelled Microtracer of GSK2118436 in Subjects With BRAF Mutant Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Paxil CR Bioequivalence Study Brazil - Fed Administration
- Status
- COMPLETED
- Phase
- PHASE1
Epidemiological, Observational and Post Marketing Study of Rotarix™ in Children With Severe Gastroenteritis in Belgium
- Status
- COMPLETED
- Phase
- N/A
Chronic Obstructive Pulmonary Disease (COPD)-Related Outcomes and Costs for Patients on Combination Fluticasone Propionate-Salmeterol Xinafoate 250/50mcg Versus Anticholinergics in a COPD-Comorbid Depression/Anxiety Population
- Status
- COMPLETED
- Phase
- N/A
Prospective Observational Study of Concomitant Allergic Rhinitis Treatment Patterns Among Patients Starting on Fluticasone Furoate Nasal Spray in a Retail Pharmacy Setting
- Status
- TERMINATED
- Phase
- N/A
Economic Analyses of the REDUCE Trial
- Status
- COMPLETED
- Phase
- N/A
Long-Term Safety Study of Retigabine Immediate Release (IR) as Adjunctive Therapy in the Treatment of Adults With Partial-Onset Seizures (POS)
- Status
- COMPLETED
- Phase
- PHASE3
A 24-week Arterial Stiffness Study With Fluticasone Furoate/Vilanterol in COPD
- Status
- COMPLETED
- Phase
- PHASE3
Demonstrating the Clinical and Economic Benefit of 5 Alpha Reductase Inhibitor Adherence in Benign Prostatic Hyperplasia
- Status
- COMPLETED
- Phase
- N/A
Hepatitis B Antibody Persistence and Immune Response to Hepatitis B Vaccine Challenge in Previously Vaccinated Children
- Status
- COMPLETED
- Phase
- PHASE4
The Role of Inflammation and Aging in HIV-Associated Cardiovascular Risk
- Status
- COMPLETED
- Phase
- N/A
A Comparison of Solid and Soluble Forms of Cold and Influenza Remedies
- Status
- COMPLETED
- Phase
- PHASE4
A Study to Investigate the Pharmacokinetics, Safety and Tolerability of GSK1349572 (Dolutegravir, DTG) in Healthy Japanese Subjects
- Status
- COMPLETED
- Phase
- PHASE1
A First Time in Human Study to Assess the Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of Single and Repeat Doses of GSK2485852 in Chronically Infected Hepatitis C Subjects
- Status
- TERMINATED
- Phase
- PHASE1